key: cord-0773292-6cmoufwd
authors: Papa, Anna; Papadimitriou, Evangelia; de Souza Luna, Luciano Kleber; Al Masri, Motassim; Souliou, Efimia; Eboriadou, Maria; Antoniadis, Antonis; Drosten, Christian
title: Coronaviruses in Children, Greece
date: 2007-06-03
journal: Emerg Infect Dis
DOI: 10.3201/eid1306.061353
sha: 5208adba66fd95d02e5358f74ce0c3a45d502c9d
doc_id: 773292
cord_uid: 6cmoufwd

nan

To the Editor: Two recently detected human coronaviruses (HCoVs), NL63 and HKU1, increased the number of coronaviruses known to infect humans to 5 (1-3). HCoV-229E and HCoV-NL63 belong to antigenic group 1, HCoV-OC43 and HCoV-HKU1 belong to antigenic group 2, and severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) is most closely related to group 2 coronaviruses. In 2005, an optimized pancoronavirus reverse transcription-PCR assay was used to explore the incidence of HCoV-NL63 infection in children in Belgium who had a diagnosis of respiratory tract infection (4) . We report the results of an epidemiologic study that used a universal coronavirus RT-PCR assay to detect coronaviruses among children in Greece with acute respiratory tract infections.

We tested throat swab specimens obtained from children hospitalized in Greece during June 2003 through May 2004 (200 children 2 months to 14 years of age, mean 4.09 years) and during December 2005 through March 2006 (44 children 1.6-8.5 years of age, mean 5.05). Specimens were obtained the fi rst day of each child's hospitalization, and all specimens were included in the study, regardless whether other respiratory microorganisms were detected.

The 25-μL reaction contained 200 μM dNTPs, 0.2 μM primer PC2S2 (equimolar mixture of 5′-TTATGGGTTGGGATTATC-3′ and 5′-TGATGGGATGGGACTATC-3′), 0.8 μM primer PC2As1 (5′-TCAT-CAGAAAGAATCATCA-3′), 1 μL of enzyme mix from the QIAGEN One-

Step RT-PCR Kit (QIAGEN GmbH, Hilden, Germany), and 5 μL of RNA. The initial 30-min reverse transcription step at 48°C was followed by 10 cycles of 20 sec at 94°C, 30 sec at 62°C with a decrease of 1°C per cycle, 40 sec at 72°C; 40 cycles of 20 sec at 94°C, 30 sec at 52°C, 40 sec at 72°C; and a fi nal extension step at 72°C for 10 min. To determine the sensitivity after optimization, we tested quantifi ed RNA in vitro transcripts that included the natural primer binding sites of the respective coronavirus genomes. Sensitivities for SARS-CoV, HCoV-OC43, HCoV-229E, and HCoV-NL63 were 61.0, 800.0, 8.2, and 82.3 nominal RNA copies per assay, respectively. A separate test was not done for HCoV-HKU1 because it had the same primer binding sites as HCoV-OC43. A phylogenetic tree based on a 400-bp genome fragment of the polymerase gene was constructed (online Appendix Figure, available from www.cdc. gov/EID/13/6/947-appG.htm).

Of 200 samples collected in 2003-2004, 5 (2.5%) were positive for coronaviruses (2 each for HCoV-NL63 and HCoV-229E and 1 for HCoV-OC43), and of 44 samples collected in 2005-2006, 2 (4.5%) were positive for coronaviruses (1 for HCoV-229E and 1 for HCoV-OC43) (GenBank accession nos. EF103180-EF103184, EF394298, and EF394299). CoV-HKU1 was not detected.

The amplifi ed genome region is one of the most conserved regions of the coronavirus genome. However, sequences for HCoV-NL63 strains isolated in Greece are genetically closer to the sequence for a strain (AY567487) isolated in Amsterdam in 2003 (1) than to a strain (AY518894) from a specimen collected in Rotterdam in 1988 (2) (0.6% vs. 1.1% nucleotide divergence). Sequences for HCoV-229E and HCoV-OC43 strains isolated in Greece differ from sequences for strains isolated elsewhere by 0.5%-1.7%.

The HCoV-NL63-positive specimens in our study were obtained from a 9-and a 14-month-old child during (Table) . HCoV-OC43 affected children with a mean age of 3.1 years (median, 1.4 years), and HCoV-229E affected children with a mean (and median) age of 5.5 years. However, no general conclusions can be drawn from these data because number of cases is too few.

None of the patients in Greece had an underlying disease, and all recovered completely. Patients infected with HCoV-229E had been hospitalized for upper respiratory tract infections, and those with HCoV-OC43 had lower respiratory tract infections; all cases were mild. Both children infected with HCoV-NL63 had symptoms of lower respiratory tract infections: 1 child had severe pneumonia and was hospitalized for 12 days, while the other had a mild course of bronchiolitis.

HCoV-NL63 was fi rst identifi ed in Amsterdam, the Netherlands, by van der Hoek et al. (1) from a nasopharyngeal specimen obtained in 2003 from a 7-month-old child with bronchiolitis, conjunctivitis, and fever. One month later, Fouchier et al.

(2) reported the characterization of the same virus isolated from a specimen collected in 1988. The specimen had been obtained from an 8-month-old child with pneumonia in Rotterdam, the Netherlands. Later, HCoV-NL63 was detected in 2.5% of bronchiolitis patients <2 years of age in Japan (5) and in most children hospitalized with bronchiolitis in Australia and Canada (6, 7) .

Coinfection with HCoVs and other respiratory viruses is frequently observed and is associated with severe clinical syndromes, especially in infants and young children (6, 8) . Coinfection was observed in 3 of the 7 HCoV-positive patients in our study. The 3 patients were infected with HCoV-OC43 or HCoV-229E; coinfection with respiratory syncytial virus was found in 2 patients, and coinfection with Mycoplasma pneumoniae was found in 1 patient. It was not possible to determine the role of the HCoVs in these coinfections. In addition, because coronaviruses can be detected even 3 weeks after an acute episode, some cases of coinfection might represent former rather than current HCoV infection (9) .

In conclusion, we detected 3 types of HCoVs in Greece: 229E, OC43, and NL63. This fi nding provides initial insight into the epidemiologic features of coronaviruses in Greece. Further studies are needed to fi nd the exact clinical effect of these HCoVs in humans and to elucidate the epidemiology of coronaviruses worldwide. 

To the Editor: Bartonella are fastidious, aerobic, gram-negative, facultative, intracellular bacteria that infect erythrocytes, erythroblasts, endothelial cells, monocytes, and dendritic cells, and are transmitted by arthropod vectors or by animal scratches or bites (1-6). Currently, 20 species or subspecies of Bartonella have been characterized, of which 8 are known zoonotic pathogens (7) . B. henselae has been recently identifi ed from canine blood (8) and from harbor porpoises (9) . Pathogenic bacteria are an important threat in terrestrial and marine environments, and in the case of B. henselae, reservoir hosts may be more diverse than currently recognized.

The purpose of this study was to determine whether sea turtles are infected with Bartonella spp. Blood samples were obtained from 29 freeranging and 8 captive, rehabilitating loggerhead sea turtles (Caretta caretta) from North Carolina coastal waters. Reptilian erythrocytes are nucleated, and commercial lysis methods clogged fi ltration columns because of the high DNA content of whole blood. Consequently, DNA was extracted from frozen whole blood by using a modifi ed alkaline lysis method adapted from an avian cell culture DNA extraction method (10). PCR screening for Bartonella was performed by using primers for the 16S-23S internal transcribed spacer (ITS) region (Table) . Bartonella ITS-positive samples were further screened by using primers for a consensus sequence of the phage-associated gene Pap31 (9) . Primers for the 28S rRNA were used as a housekeeping gene. The PCR-positive control contained 0.002 pg/μL of B. henselae H1. Water was the negative PCR control. Amplicons of the expected sizes were consistently obtained from housekeeping gene and positive control reactions, while amplicons were never obtained from negative controls. ITS amplicons were obtained from 16 (43%) of 37 sea turtle blood samples tested, including samples from 13 free-ranging and 3 rehabilitated turtles. Pap31 PCR was performed for Bartonella ITS-PCR-positive samples. Pap31 amplicons were obtained from 5 samples of which 3 were successfully sequenced. Amplifi cation and sequencing of the 16S-23S ITS region detected 2 Bartonella species: a B. henselae-like organisms and 1 more similar to B. vinsonii subsp. berkhoffi i. The 3 Pap31 amplicons successfully sequenced confi rmed B. henselae infection. Sequences obtained from 1 sample matched B. henselae strains H1-like, the B. henselae SA2-like strain, and B. vinsonii subsp. berkhoffi i genotypes II and IV, which suggests that this turtle was co-infected with multiple Bartonella spp. and strains. Three other samples yielded amplicons 99%-100% identical with B. henselae strain SA2, and 3 yielded sequences most similar to B. vinsonii subspecies berkhoffi i genotypes II and IV. Two samples contained an ITS region sequence most similar to B. henselae SA2, but with a 15-bp deletion beginning 617 bases downstream from the 16S rRNA gene. Whether these ITS sequence differences represent distinct strains or nonrandom translocation events is uncertain.

Four sea turtle blood samples contained partial ITS sequences most similar to B. vinsonii subsp. berkhoffi i. However these amplicons were much shorter than expected for B. vinsonii subspecies berkhoffi i genotype II and genotype IV sequences in GenBank. Because Pap31 gene amplifi cation was unsuccessful for these samples, it is unclear whether small amplicons represent a species related to B. vinsonii subsp. berkhoffi i or a new Bartonella sp. 

Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia

A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium

Detection of human coronavirus NL63 in young children with bronchiolitis

New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia

Human coronavirus NL-63 infections in children: a 1-year study

Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients

Human coronavirus NL63 associated with lower respiratory tract symptoms in early life